We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+14.05%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$12.1B
AUM Growth
+$1.64B
Cap. Flow
+$978M
Cap. Flow %
8.07%
Top 10 Hldgs %
60.36%
Holding
446
New
110
Increased
68
Reduced
64
Closed
143

Top Buys

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$644M
2
PPD
PPD, Inc. Common Stock
PPD
+$547M
3
KSU
Kansas City Southern
KSU
+$446M
4
PFPT
Proofpoint, Inc.
PFPT
+$409M
5
INFO
IHS Markit Ltd. Common Shares
INFO
+$220M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$481M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$456M
3
IPHI
INPHI CORPORATION
IPHI
+$365M
4
CLGX
Corelogic, Inc.
CLGX
+$311M
5
VAR
Varian Medical Systems, Inc.
VAR
+$268M

Sector Composition

Rank Sector Weight
1 Technology 19.76%
2 Healthcare 16.44%
3 Communication Services 8.82%
4 Industrials 6.64%
5 Consumer Discretionary 4.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TIG
251
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$437K ﹤0.01%
29,000
-1,000
-3% -$16.3K
SRNGU
252
DELISTED
Soaring Eagle Acquisition Corp. Unit
SRNGU
$424K ﹤0.01%
40,000
– –
TRQ
253
PUT
DELISTED
Turquoise Hill Resources Ltd
TRQ
$422K ﹤0.01%
+25,000
New +$443K
PRPC.U
254
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
$400K ﹤0.01%
40,000
– –
CHWY icon
255
Chewy
CHWY
$9.63B
$399K ﹤0.01%
+5,000
New +$387K
PMGMU
256
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
$398K ﹤0.01%
40,000
– –
CNVY
257
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$398K ﹤0.01%
+35,000
New +$405K
GCAC
258
DELISTED
Growth Capital Acquisition Corp. Class A Common Stock
GCAC
$392K ﹤0.01%
+40,458
New +$394K
CSTL icon
259
Castle Biosciences
CSTL
$979M
$367K ﹤0.01%
5,000
-3,381
-40% -$223K
CSTL icon
260
PUT
Castle Biosciences
CSTL
$979M
$367K ﹤0.01%
+5,000
New +$330K
BCYC
261
Bicycle Therapeutics
BCYC
$292M
$364K ﹤0.01%
12,000
– –
BWMN icon
262
Bowman Consulting
BWMN
$477M
$361K ﹤0.01%
+26,057
New +$357K
DGNU
263
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$350K ﹤0.01%
35,000
– –
GRBK icon
264
Green Brick Partners
GRBK
$3.14B
$341K ﹤0.01%
15,000
-40,000
-73% -$958K
SMWB icon
265
Similarweb
SMWB
$658M
$335K ﹤0.01%
+17,000
New +$352K
DYN icon
266
Dyne Therapeutics
DYN
$4.9B
$316K ﹤0.01%
15,000
– –
NRDY icon
267
Nerdy
NRDY
$96.7M
$315K ﹤0.01%
31,700
+1,700
+6% +$17.2K
HYFM icon
268
Hydrofarm Holdings
HYFM
$7.62M
$296K ﹤0.01%
+500
New +$294K
MQ icon
269
Marqeta
MQ
$1.66B
$281K ﹤0.01%
+2,500
New +$298K
FACA.U
270
DELISTED
Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
FACA.U
$259K ﹤0.01%
25,000
– –
GTPBU
271
DELISTED
Gores Technology Partners II, Inc. Units
GTPBU
$258K ﹤0.01%
25,000
– –
KRT icon
272
Karat Packaging
KRT
$940M
$255K ﹤0.01%
+12,500
New +$238K
FTAAU
273
DELISTED
FTAC Athena Acquisition Corp. Unit
FTAAU
$255K ﹤0.01%
25,000
– –
NDACU
274
DELISTED
NightDragon Acquisition Corp. SCALE Units
NDACU
$252K ﹤0.01%
25,000
– –
HERAU
275
DELISTED
FTAC Hera Acquisition Corp. Units
HERAU
$251K ﹤0.01%
25,000
– –
9 10
11
12 13

Similar funds

CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

Pentwater Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Pentwater Capital Management held 446 positions worth $12.1B, up 16% from $10.5B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Pentwater Capital Management deployed $978M of net new capital in Q2 2021, opening 110 new positions and adding to 68 existing holdings. Its largest new stake was Nuance Communications, Inc.: 12,230,000 shares worth $666M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Xilinx Inc, an estimated $481M trimmed.

  • Pentwater Capital Management's largest Q2 2021 buy was Nuance Communications, Inc.: 12,230,000 shares worth $666M.
  • Pentwater Capital Management added most to PPD, Inc. Common Stock in Q2 2021, an estimated $547M increase.
  • Pentwater Capital Management's biggest Q2 2021 reduction was Xilinx Inc, cutting an estimated $481M.
  • Pentwater Capital Management fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $456M.
  • Pentwater Capital Management's ten largest holdings make up 60% of its $12.1B portfolio in Q2 2021.
  • Pentwater Capital Management opened 110 new positions and closed 143 in Q2 2021.
  • Pentwater Capital Management's portfolio value rose 16% quarter-over-quarter to $12.1B.

Based on Pentwater Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.